Cambridge, MA, United States of America

Matthew Rausch

USPTO Granted Patents = 5 

Average Co-Inventor Count = 11.4

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Matthew Rausch: Innovator in Antibody Therapeutics

Introduction

Matthew Rausch is a prominent inventor based in Cambridge, MA (US), known for his significant contributions to the field of antibody therapeutics. With a total of 5 patents, Rausch has focused on developing innovative solutions for treating diseases, particularly cancer.

Latest Patents

Among his latest patents are the "Anti-IL-27 antibodies and uses thereof," which relates to anti-IL-27 antibodies and their potential applications in treating or ameliorating symptoms of diseases such as cancer. This patent also includes methods for detecting IL-27 in subjects or samples. Another notable patent is for "Anti-CD39 antibody compositions and methods," which provides compositions for anti-CD39 antibodies and their use in cancer treatment.

Career Highlights

Rausch has worked with several notable companies in the biotechnology sector, including Surface Oncology, Inc. and Adimab, LLC. His work in these organizations has contributed to advancements in cancer therapies and antibody development.

Collaborations

Matthew Rausch has collaborated with esteemed colleagues, including Scott C Chappel and Andrew Lake, further enhancing the impact of his work in the field.

Conclusion

Matthew Rausch's innovative work in antibody therapeutics showcases his dedication to advancing medical science and improving treatment options for patients. His contributions are significant in the ongoing fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…